Scientific Publications

Search by Keyword(s)
Found 13 results

Filters: Author is DeAngelo, DJ  [Clear All Filters]

Search Results

  • Showing 1-13 of 13 Results
2016
Targeting MTHFD2 in acute myeloid leukemia.Pikman, Y., Puissant A., Alexe G., Furman A., Chen LM, Frumm SM, Ross L., Fenouille N., Bassil CF, Lewis CA, Ramos A., Gould J., Stone RM, DeAngelo DJ, Galinsky I., Clish CB, Kung AL, Hemann MT, Vander Heiden MG, Banerji V., et al. The Journal of experimental medicine, 2016/06/20, (2016) Read More / View Supplemental Materials
Abstract
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.Townsend, EC, Murakami MA, Christodoulou A., Christie AL, Köster J., DeSouza TA, Morgan EA, Kallgren SP, Liu H., Wu SC, Plana O., Montero J., Stevenson KE, Rao P., Vadhi R., Andreeff M., Armand P., Ballen KK, Barzaghi-Rinaudo P., Cahill S., et al. Cancer cell, 2016/04/11, Volume 29, Issue 4, p.574-86, (2016) Read More / View Supplemental Materials
Abstract
2015
RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability.Chen, E., Ahn JS, Sykes DB, Breyfogle LJ, Godfrey AL, Nangalia J., Ko A., DeAngelo DJ, Green AR, and Mullally A. Cell reports, 2015/12/22, Volume 13, Issue 11, p.2345-52, (2015) Read More / View Supplemental Materials
Abstract
Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case.Knoechel, B., Bhatt A., Pan L., Pedamallu CS, Severson E., Gutierrez A., Dorfman DM, Kuo FC, Kluk M., Kung AL, Zweidler-McKay P., Meyerson M., Blacklow SC, DeAngelo DJ, and Aster J. C. Cold Spring Harbor molecular case studies, 2015/10/01, Volume 1, Issue 1, p.a000539, (2015) Read More / View Supplemental Materials
Abstract
Epidemiologic Investigation of a Cluster of Neuroinvasive Bacillus cereus Infections in 5 Patients With Acute Myelogenous Leukemia.Rhee, C., Klompas M., Tamburini FB, Fremin BJ, Chea N., Epstein L., Halpin AL, Guh A., Gallen R., Coulliette A., Gee J., Hsieh C., Desjardins CA, Pedamullu CS, DeAngelo DJ, Manzo VE, Folkerth RD, Milner DA Jr, Pecora N., Osborne M., et al. Open forum infectious diseases, 2015/09/01, Volume 2, Issue 3, p.ofv096, (2015) Read More / View Supplemental Materials
Abstract
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.Wu, SC, Li LS, Kopp N., Montero J., Chapuy B., Yoda A., Christie AL, Liu H., Christodoulou A., van Bodegom D., van der Zwet J., Layer JV, Tivey T., Lane AA, Ryan JA, Ng SY, DeAngelo DJ, Stone RM, Steensma D., Wadleigh M., et al. Cancer cell, 2015/07/13, Volume 28, Issue 1, p.29-41, (2015) Read More / View Supplemental Materials
Abstract
2014
SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia.Puissant, A., Fenouille N., Alexe G., Pikman Y., Bassil CF, Mehta S., Du J., Kazi JU, Luciano F., Rönnstrand L., Kung AL, Aster J. C., Galinsky I., Stone RM, DeAngelo DJ, Hemann MT, and Stegmaier K. Cancer cell, 2014/02/10, Volume 25, Issue 2, p.226-42, (2014) Read More / View Supplemental Materials
Abstract
2013
A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia.DeAngelo, DJ, Neuberg D., Amrein PC, Berchuck J., Wadleigh M., Sirulnik LA, Galinsky I., Golub T., Stegmaier K., and Stone RM Leukemia research, 2013/11/05, (2013) Read More / View Supplemental Materials
Abstract
2010
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease.Bradner, JE, Mak R., Tanguturi SK, Mazitschek R., Haggarty SJ, Ross K., Chang CY, Bosco J., West N., Morse E., Lin K., Shen JP, Kwiatkowski NP, Gheldof N., Dekker J., DeAngelo DJ, Carr SA, Schreiber SL, Golub T. R., and Ebert BL Proceedings of the National Academy of Sciences of the United States of America, 2010/07/13, Volume 107, Issue 28, p.12617-22, (2010) Read More / View Supplemental Materials
Abstract
2009
Proteomic and genetic approaches identify Syk as an AML target.Hahn, CK, Berchuck JE, Ross KN, Kakoza RM, Clauser K., Schinzel AC, Ross L., Galinsky I., Davis TN, Silver SJ, Root DE, Stone RM, DeAngelo DJ, Carroll M., Hahn WC, Carr SA, Golub T. R., Kung AL, and Stegmaier K. Cancer cell, 2009/10/06, Volume 16, Issue 4, p.281-94, (2009) Read More / View Supplemental Materials
Abstract
Identification of AML1-ETO modulators by chemical genomics.Corsello, SM, Roti G., Ross KN, Chow KT, Galinsky I., DeAngelo DJ, Stone RM, Kung AL, Golub T. R., and Stegmaier K. Blood, 2009/06/11, Volume 113, Issue 24, p.6193-205, (2009) Read More / View Supplemental Materials
Abstract
2006
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.Pikman, Y., Lee BH, Mercher T., McDowell E., Ebert BL, Gozo M., Cuker A., Wernig G., Moore S., Galinsky I., DeAngelo DJ, Clark JJ, Lee SJ, Golub T. R., Wadleigh M., Gilliland DG, and Levine RL PLoS medicine, 2006/07/01, Volume 3, Issue 7, p.e270, (2006) Read More / View Supplemental Materials
Abstract
2005
Gefitinib induces myeloid differentiation of acute myeloid leukemia.Stegmaier, K., Corsello SM, Ross KN, Wong JS, DeAngelo DJ, and Golub T. R. Blood, 2005/10/15, Volume 106, Issue 8, p.2841-8, (2005) Read More / View Supplemental Materials
Abstract
  • Showing 1-13 of 13 Results